Certara Stock Today
| CERT Stock | USD 10.92 0.49 4.70% |
PerformanceVery Weak
| Odds Of DistressLow
|
Certara is selling for under 10.92 as of the 16th of March 2025; that is 4.70 percent increase since the beginning of the trading day. The stock's last reported lowest price was 10.45. Certara has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 11th of December 2020 | Category Healthcare | Classification Health Care |
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. The company has 161.02 M outstanding shares of which 6.17 M shares are currently shorted by private and institutional investors with about 3.78 trading days to cover. More on Certara
Moving together with Certara Stock
Moving against Certara Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Certara Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President Software | Robert Aspbury | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Technology, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCertara can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Certara's financial leverage. It provides some insight into what part of Certara's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certara (CERT) is traded on NASDAQ Exchange in USA. It is located in 4 Radnor Corporate Center, Radnor, PA, United States, 19087 and employs 1,487 people. Certara is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.76 B. Certara conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 161.02 M outstanding shares of which 6.17 M shares are currently shorted by private and institutional investors with about 3.78 trading days to cover.
Certara currently holds about 195.44 M in cash with 80.47 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22.
Check Certara Probability Of Bankruptcy
Ownership AllocationCertara holds a total of 161.02 Million outstanding shares. The majority of Certara outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Certara to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Certara. Please pay attention to any change in the institutional holdings of Certara as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Certara Ownership Details
Certara Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Mackenzie Investments | 2024-12-31 | 3.4 M | |
| Jpmorgan Chase & Co | 2024-12-31 | 2.5 M | |
| Riverbridge Partners Llc | 2024-12-31 | 2.2 M | |
| Bank Of New York Mellon Corp | 2024-12-31 | 2 M | |
| Geode Capital Management, Llc | 2024-12-31 | 1.9 M | |
| Daventry Group, Lp | 2024-12-31 | 1.6 M | |
| Citadel Advisors Llc | 2024-12-31 | 1.6 M | |
| Glenmede Trust Co Na | 2024-12-31 | 1.5 M | |
| London Company Of Virginia | 2024-12-31 | 1.4 M | |
| Blackrock Inc | 2024-12-31 | 13.8 M | |
| Vanguard Group Inc | 2024-12-31 | 12.4 M |
Certara Historical Income Statement
Certara Stock Against Markets
Certara Corporate Management
| Richard Traynor | General VP | Profile | |
| Frederic Bois | Head Advisor | Profile | |
| Sheila MBA | Chief Officer | Profile | |
| Ron DiSantis | Senior Development | Profile | |
| David Mitchell | Senior Engagement | Profile |
Additional Tools for Certara Stock Analysis
When running Certara's price analysis, check to measure Certara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Certara is operating at the current time. Most of Certara's value examination focuses on studying past and present price action to predict the probability of Certara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Certara's price. Additionally, you may evaluate how the addition of Certara to your portfolios can decrease your overall portfolio volatility.